Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study.
CNS Drugs. 2023 Aug;37(8):715-723. doi: 10.1007/s40263-023-01026-3. Epub 2023 Aug 9.
CNS Drugs. 2023.
PMID: 37558912
Free PMC article.
Factors associated with COVID-19 Infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United States.
Liberman JN, Pesa J, Petrillo MP, Ruetsch C.
Liberman JN, et al. Among authors: petrillo mp.
BMC Psychiatry. 2022 Jun 2;22(1):376. doi: 10.1186/s12888-022-04026-7.
BMC Psychiatry. 2022.
PMID: 35655167
Free PMC article.
Item in Clipboard
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery-Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire.
Kern Sliwa J, Naranjo RR Jr, Turkoz I, Petrillo MP, Cabrera P, Trivedi M.
Kern Sliwa J, et al. Among authors: petrillo mp.
CNS Spectr. 2024 Apr 1:1-11. doi: 10.1017/S1092852924000105. Online ahead of print.
CNS Spectr. 2024.
PMID: 38557430
Item in Clipboard
Cite
Cite